Olfr612 Inhibitors
Or51aa2, a member of the olfactory receptor family, functions as a G-protein-coupled receptor (GPCR) involved in olfactory signal transduction. This receptor plays a crucial role in detecting odorant molecules, initiating a neuronal response that leads to the perception of smells. The olfactory receptor gene family, the largest in the genome, underscores the significance of olfaction in sensory perception. Inhibition of Or51aa2 can be achieved through both direct and indirect mechanisms. Direct inhibitors, such as specific antagonists designed to block the binding of odorant molecules to Or51aa2, disrupt the normal olfactory response. Indirect inhibitors, including compounds like zinc sulfate, rolipram, and forskolin, modulate key elements of the olfactory transduction pathway, influencing the receptor's sensitivity to odorant stimuli.
Understanding the intricate mechanisms involved in Or51aa2 inhibition provides valuable insights into the complexities of olfactory signal transduction and the potential modulation of odor perception. Investigation of these inhibitors offers tools to unravel the molecular intricacies of Or51aa2 function within the broader olfactory receptor gene family, contributing to our understanding of sensory perception at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc sulfate indirectly inhibits Or51aa2 by modulating the olfactory transduction pathway. Zinc ions have been shown to influence olfactory receptor activity, potentially affecting the recognition of odorant molecules by Or51aa2. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a phosphodiesterase inhibitor (PDE4) that indirectly influences Or51aa2 by preventing cyclic nucleotide degradation. This compound enhances olfactory signal transduction by maintaining elevated cAMP levels, potentially affecting the sensitivity of Or51aa2 to odorant stimuli. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin inhibits G proteins and indirectly affects Or51aa2 by disrupting downstream signaling cascades. This compound interferes with GPCR-mediated transduction of olfactory signals, potentially modulating the overall olfactory response. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
SQ 22536 is an adenylate cyclase inhibitor, indirectly impacting Or51aa2 by reducing cAMP synthesis. This compound modulates olfactory signal transduction pathways, potentially affecting the sensitivity of Or51aa2 to odorant stimuli. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $43.00 $104.00 $328.00 | 3 | |
Methylene Blue inhibits guanylyl cyclase, indirectly influencing Or51aa2 signaling by altering cGMP levels. This compound modulates olfactory transduction pathways, potentially affecting the receptor's sensitivity to odorant molecules. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cell-permeable cAMP analogue, directly impacting Or51aa2 by mimicking the second messenger involved in olfactory signal transduction. This compound modulates intracellular signaling cascades, potentially affecting the receptor's sensitivity to odorant stimuli and altering the overall olfactory response. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 is a calmodulin antagonist, indirectly inhibiting Or51aa2 by disrupting calcium-dependent processes. This compound alters olfactory signal transduction pathways, potentially influencing the receptor's sensitivity to odorant stimuli and impacting the overall olfactory response. | ||||||
NF 023 | 104869-31-0 | sc-204124 sc-204124A | 10 mg 50 mg | $161.00 $629.00 | 1 | |
NF023 is an inhibitor of protein kinase A (PKA), indirectly affecting Or51aa2 by suppressing phosphorylation events. This compound modulates olfactory transduction pathways, potentially altering the sensitivity of Or51aa2 to odorant stimuli and impacting the overall olfactory response. | ||||||
ODQ | 41443-28-1 | sc-200325 sc-200325A | 10 mg 50 mg | $78.00 $222.00 | 13 | |
ODQ is a guanylyl cyclase inhibitor, indirectly impacting Or51aa2 by reducing cGMP levels. This compound modulates olfactory transduction pathways, potentially affecting the receptor's sensitivity to odorant stimuli. | ||||||